Pentixapharm Holding AG (VIE:PTPN)
Austria
· Delayed Price · Currency is EUR 1.488
+0.012 (0.81%)
At close: Dec 5, 2025
Pentixapharm Holding AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 0.9 | 0.78 | 4.77 | 3.97 | 2.6 |
| Other Revenue | 0.62 | 0.62 | 1.74 | - | 0 |
| Revenue | 1.52 | 1.4 | 6.51 | 3.97 | 2.6 |
| Revenue Growth (YoY) | -63.61% | -78.47% | 64.04% | 52.67% | - |
| Cost of Revenue | 8.46 | 3.74 | 0.05 | - | - |
| Gross Profit | -6.94 | -2.33 | 6.46 | 3.97 | 2.6 |
| Selling, General & Admin | 6.34 | 2.26 | 2.29 | 1.26 | 1.13 |
| Other Operating Expenses | 4.31 | 2.73 | 10.11 | 4.78 | 3.01 |
| Operating Expenses | 13.51 | 5.06 | 12.55 | 6.16 | 4.24 |
| Operating Income | -20.45 | -7.39 | -6.09 | -2.19 | -1.64 |
| Interest Expense | -0.1 | -0.1 | -0.18 | - | -0 |
| Interest & Investment Income | 0.78 | 0.57 | 0.13 | - | - |
| Earnings From Equity Investments | - | - | - | 1.4 | -0.09 |
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0.07 | -0 | -0 |
| Other Non Operating Income (Expenses) | 0.04 | - | - | 0.01 | - |
| EBT Excluding Unusual Items | -19.72 | -6.91 | -6.21 | -0.78 | -1.73 |
| Impairment of Goodwill | -0.78 | -0.78 | - | - | - |
| Gain (Loss) on Sale of Assets | 6.7 | 6.7 | - | - | - |
| Asset Writedown | -18.24 | -18.24 | - | - | - |
| Other Unusual Items | 1.72 | 1.72 | - | - | - |
| Pretax Income | -30.31 | -17.5 | -6.21 | -0.78 | -1.73 |
| Income Tax Expense | -3.81 | -3.52 | 1.43 | 1.18 | 0.76 |
| Net Income | -26.5 | -13.98 | -7.64 | -1.96 | -2.49 |
| Net Income to Common | -26.5 | -13.98 | -7.64 | -1.96 | -2.49 |
| Shares Outstanding (Basic) | 43 | 25 | 22 | - | - |
| Shares Outstanding (Diluted) | 43 | 25 | 22 | - | - |
| Shares Change (YoY) | 99.69% | 14.21% | - | - | - |
| EPS (Basic) | -0.61 | -0.56 | -0.35 | - | - |
| EPS (Diluted) | -0.61 | -0.57 | -0.35 | - | - |
| Free Cash Flow | -23.56 | -7.35 | -2.81 | -6.24 | -4.1 |
| Free Cash Flow Per Share | -0.54 | -0.30 | -0.13 | - | - |
| Gross Margin | - | -166.38% | 99.17% | 100.00% | 100.00% |
| Operating Margin | -1345.84% | -527.20% | -93.49% | -55.02% | -63.09% |
| Profit Margin | -1743.86% | -996.43% | -117.27% | -49.38% | -95.81% |
| Free Cash Flow Margin | -1550.41% | -524.24% | -43.18% | -157.24% | -157.75% |
| EBITDA | -17.68 | -7.33 | -5.94 | -2.07 | -1.54 |
| EBITDA Margin | - | - | -91.23% | -52.15% | -59.02% |
| D&A For EBITDA | 2.77 | 0.07 | 0.15 | 0.11 | 0.11 |
| EBIT | -20.45 | -7.39 | -6.09 | -2.19 | -1.64 |
| EBIT Margin | - | - | -93.49% | -55.02% | -63.09% |
Source: S&P Capital IQ. Standard template. Financial Sources.